Relaparotomy for pancreatic fistula after pancreatoduodenectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24103

Enrollment

140

Registered

2019-03-11

Start date

2019-03-11

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pancreatic fistula

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing relaparotomy for pancreatic fistula after pancreatoduodenectomy

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Mortality	—

Secondary

Measure	Time frame
New-onset organ failure, pancreatectomy specific complication in accordance to the International Study Group on Pancreatic Surgery definitions and grading (i.e. postpancreatectomy hemorrhage, bile leakage, delayed gastric emptying, chyle leak), length of Intensive Care Unit (ICU) stay, length of hospital stay, duration of pancreatic fistula (calculated as time from pancreatoduodenectomy to completion pancreatectomy or removal of last abdominal drain), the number and type of subsequent invasive interventions after first relaparotomy for pancreatic fistula, adjuvant therapy, development of postoperative new endocrine and exocrine pancreatic insufficiency	—

Measure

Time frame

New-onset organ failure, pancreatectomy specific complication in accordance to the International Study Group on Pancreatic Surgery definitions and grading (i.e. postpancreatectomy hemorrhage, bile leakage, delayed gastric emptying, chyle leak), length of Intensive Care Unit (ICU) stay, length of hospital stay, duration of pancreatic fistula (calculated as time from pancreatoduodenectomy to completion pancreatectomy or removal of last abdominal drain), the number and type of subsequent invasive interventions after first relaparotomy for pancreatic fistula, adjuvant therapy, development of postoperative new endocrine and exocrine pancreatic insufficiency

—

Contacts

Public ContactJesse Groen J10.71

LUMC

J.V.Groen@lumc.nl0653567632

Outcome results